Menu
Washingtoner
  • Home
  • Health
  • Boeing
  • Daryl Guberman
  • Aerospace
  • Technology
  • Business
  • Lifestyle
  • ANSI-ANAB
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Tacoma: City Council Takes Steps to Further Activate and Support High-Investment Corridors
  • Spokane: Child Injured in Basement Fire Reminds About Youth Fire Setting
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Spokane: SPD is Seeking Public's Assistance in Locating Dangerous Offender
  • Spokane: Flags to be Lowered for Memorial Day
  • Color Card Administrator Highlights Growing Enterprise Demand for Operational Infrastructure in Business Card Identity Governance
  • American Properties Celebrates Grand Opening and Ribbon Cutting Ceremony at Heritage at South
  • Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Lansdowne Photographer Steven Weisz Selected for Philadelphia City Hall Exhibition
  • HiLine Homes Named Gold Winner in Best of Southwest Washington Home & Garden Awards
  • Federal indictments bring new scrutiny to SPLC practices and highlight the real‑world impact of its designations on nonprofit groups, including NCFM
  • Shedrack Anderson Releases New Album
  • Could You Make a 2026 World Cup Squad? A New Free Tool Will Tell You Where You'd Sit on Any National Team's Bench in 90 Seconds
  • Snap Supplements Releases Results of 90-Day Prostate Health Open-Label Pilot Study
  • Sugar Land's Social Scene Gets a Boost: Pep's Backyard Set to Open Near Constellation Field
  • Joseph Nybyk (AKA Joseph Neibich) Guests On Octopus TV
  • Mutant-Fueled Bio-Cyberpunk Shooter HoverGrease 2 Launches May 22
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • XRPPower Continues Strengthening Its Global AI-Powered Blockchain Ecosystem
  • Spokane: Coffee Connect With District 1 Council Members
  • Spokane: Coffee With Council District 2 Council Members
  • Tacoma: Implementation of Transportation Impact Fees to Begin on June 1
  • City of Tacoma Highlights Performance Milestones, Efficiency of Alternative Response Programs
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • FutureLot Powers ADU Wizard for Massachusetts Clean Energy Center's Statewide ADU Resource Center
  • ICT Innovations Releases ICTPBX Community Edition as Open Source Under Mozilla Public License 2.0
  • Spokane: City Closures Planned for Memorial Day
  • Spokane: Child Injured in Basement Fire Reminds About Youth Fire Setting
_catLbl0 _catLbl1

Popular on Washingtoner

  • Altruvest and Financial Executives International Canada Announce Strategic Partnership to Strengthen Nonprofit Boards Across Canada
  • Freedomtech Solutions creates 'Global Data Centre Network (IDCN)'
  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Axencis Launches Performance Partnership for Brand Protection
  • Project Pretzel Introduces a New System for Running Renovation Projects with Built In Contracts and Real Time Execution
  • Spokane: Abor Day Celebration 2026
  • Advanced TeleSensors Appoints AgeTech Innovator Tiffany Wey, MBA as Vice President of Sales & Marketing
  • Five-star Review for Berklee School of Music Textbook
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative

Similar on Washingtoner

  • Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America
  • Love Must Be the Guide: Live Good Shares a Message of Humanity, Compassion and Hope
  • Crosswalk Ministries USA Announces 2026 Child and Family Well-Being Conference in Stockbridge, Georgia
  • Snap Supplements Releases Results of 90-Day Prostate Health Open-Label Pilot Study
  • Sugar Land's Social Scene Gets a Boost: Pep's Backyard Set to Open Near Constellation Field
  • Triple-Digit Growth, OTCQX Market Upgrade and a Rapidly Expanding Specialty Healthcare Platform: Cardiff Lexington Corporation: Stock Symbol: CDIX
  • Lick Introduces Pineapple Flavored Massage Oil — A Tropical Date Night Favorite Available on Amazon
  • Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
  • Raymond Lavine, Extended Care Benefits Advisor and Author, to Appear on National Television Series Moving America Forward
  • NaturismRE Launches Structured Nudism & Naturism Encyclopedia, Aiming to Reframe Public Understanding
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute